Isavuconazole as salvage therapy for mucormycosis

Bianca Graves, C. Orla Morrissey, Andrew Wei, John Coutsouvelis, Samantha J Ellis, Alan Pham, Julian Gooi, Michelle Ananda-Rajah

Research output: Contribution to journalArticleOtherpeer-review

17 Citations (Scopus)


Mucormycosis carries a high mortality rate with few therapeutic options available. We describe a man with pulmonary/splenic mucormycosis complicating hypoplastic myelodysplastic syndrome on a background of chronic kidney disease, who achieved a complete response with salvage isavuconazole therapy following intolerance of consecutive courses of liposomal amphotericin and posaconazole therapy.

Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalMedical Mycology Case Reports
Publication statusPublished - 1 Mar 2016


  • Isavuconazole
  • Mucormycosis

Cite this